Jeil Pharmaceutical Co Ltd (271980) — Cash Flow Quality Index
Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Quality Index of 0.07x as of December 2025. Operating cash flow of ₩532.03 Million is below net income of ₩7.36 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Jeil Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jeil Pharmaceutical Co Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Jeil Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd (2017–2025)
Year-by-year earnings quality comparison for Jeil Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.24x | ₩-5.69 Billion | ₩23.38 Billion | ▲ +75.6% |
| 2023 | -1.00x | ₩-4.98 Billion | ₩5.00 Billion | ▲ +63.9% |
| 2020 | -2.75x | ₩-19.05 Billion | ₩6.92 Billion | ▼ -124.2% |
| 2018 | 11.36x | ₩21.45 Billion | ₩1.89 Billion | ▲ +388.0% |
| 2017 | -3.94x | ₩-4.21 Billion | ₩1.07 Billion | — |